Vistagen Therapeutics Inc (VTGN)

01:38 AM

VistaGen Therapeutics: Promising Prospects for Fasedienol in Social Anxiety Disorder - TipRanks

01:38 AM

09:19 AM

Vistagen Therapeutics (VTGN): Examining Valuation After Phase 3 Trial Progress Toward Social Anxiety Treatment Approval - Yahoo Finance

09:19 AM

06:24 AM

Published on: 2025-11-04 05:24:21 - newser.com

06:24 AM

05:51 AM

Is Vistagen Therapeutics Inc. stock reversal real or fakeShare Buyback & Verified Momentum Stock Watchlist - newser.com

05:51 AM

05:26 AM

Should you hold or exit Vistagen Therapeutics Inc. nowTrade Exit Summary & Trade Opportunity Analysis - newser.com

05:26 AM

04:43 AM

How Vistagen Therapeutics Inc. stock compares to industry benchmarksWeekly Earnings Recap & AI Powered Buy/Sell Recommendations - newser.com

04:43 AM

03:50 AM

Is Vistagen Therapeutics Inc. stock attractive for income investorsAnalyst Downgrade & Risk Controlled Daily Plans - newser.com

03:50 AM

01:40 AM

Technical signs of recovery in Vistagen Therapeutics Inc.July 2025 Weekly Recap & Daily Profit Focused Stock Screening - newser.com

01:40 AM

Nov 03, 2025

Using RSI to spot recovery in Vistagen Therapeutics Inc.July 2025 Sector Moves & Verified Swing Trading Watchlists - newser.com

Nov 03, 2025

Nov 03, 2025

How to recover losses in Vistagen Therapeutics Inc. stock2025 Volatility Report & Free Expert Verified Stock Movement Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Will Vistagen Therapeutics Inc. stock remain a Wall Street favorite2025 Short Interest & Daily Technical Stock Forecast Reports - newser.com

Nov 03, 2025

Nov 03, 2025

VistaGen stock rises after completing Phase 3 trial for anxiety drug By Investing.com - Investing.com Nigeria

Nov 03, 2025

Nov 03, 2025

VistaGen stock rises after completing Phase 3 trial for anxiety drug - Investing.com Nigeria

Nov 03, 2025

Nov 03, 2025

What dividend safety score for Vistagen Therapeutics Inc. stockMarket Risk Analysis & Short-Term Trading Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Is Vistagen Therapeutics Inc. a candidate for recovery play2025 Earnings Surprises & Low Drawdown Investment Strategies - newser.com

Nov 03, 2025

Nov 03, 2025

Vistagen Therapeutics Inc. stock trend outlook and recovery pathWeekly Trend Summary & Safe Entry Point Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Can Vistagen Therapeutics Inc. stock deliver surprise earnings beat2025 Stock Rankings & Real-Time Volume Triggers - newser.com

Nov 03, 2025

Nov 03, 2025

Vistagen (NASDAQ: VTGN) completes PALISADE-3 Phase 3; topline results due year end - Stock Titan

Nov 03, 2025

Nov 03, 2025

Vistagen Therapeutics Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView

Nov 03, 2025

Nov 03, 2025

Strategies to average down on Vistagen Therapeutics Inc.Risk Management & Safe Entry Zone Identification - newser.com

Nov 03, 2025

Nov 03, 2025

Will breakout in Vistagen Therapeutics Inc. lead to full recoveryEarnings Miss & High Return Trade Opportunity Guides - newser.com

Nov 03, 2025

Nov 03, 2025

Will Vistagen Therapeutics Inc. stock benefit from green energy trends2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com

Nov 03, 2025

Nov 02, 2025

Is Vistagen Therapeutics Inc. stock a safe haven assetWeekly Stock Recap & High Accuracy Trade Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Will Vistagen Therapeutics Inc. stock gain from strong economy2025 Top Decliners & Fast Gain Swing Trade Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Using fundamentals and technicals on Vistagen Therapeutics Inc.Earnings Recap Summary & Low Volatility Stock Recommendations - newser.com

Nov 02, 2025

Nov 01, 2025

Visualizing Vistagen Therapeutics Inc. stock with heatmapsOptions Play & Technical Pattern Alert System - newser.com

Nov 01, 2025

Nov 01, 2025

Published on: 2025-11-01 04:45:37 - newser.com

Nov 01, 2025

Oct 31, 2025

Combining machine learning predictions for Vistagen Therapeutics Inc.CEO Change & Reliable Price Action Trade Plans - newser.com

Oct 31, 2025

Oct 31, 2025

How to escape a deep drawdown in Vistagen Therapeutics Inc.Day Trade & Low Risk Investment Opportunities - newser.com

Oct 31, 2025